CLINICAL USE


Second line haemostatic agent for uraemic bleeding

DOSE IN NORMAL RENAL FUNCTION

0.6 mg/kg/day for 5 days

PHARMACOKINETICS

  • Molecular weight &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :–
  • %Protein binding &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :–
  • %Excreted unchanged in urine &nbsp &nbsp : –
  • Volume of distribution (L/kg) &nbsp &nbsp &nbsp :–
  • half-life – normal/ESRD (hrs)&nbsp &nbsp &nbsp :–

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50 &nbsp &nbsp : Dose as in normal renal function
  • 10 to 20 &nbsp &nbsp : Dose as in normal renal function
  • <10 &nbsp &nbsp &nbsp &nbsp &nbsp : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp:Unknown dialysability. Dose as in normal renal function

  • HD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :Unknown dialysability. Dose as in normal renal function
  • HDF/high flux &nbsp :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD &nbsp &nbsp &nbsp:Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Ciclosporin: concentration of ciclosporin increased
  • Anticoagulants: antagonism of anticoagulant effect of coumarins and phenindione
  • Anti-epileptics: accelerate metabolism of oestrogens

    ADMINISTRATION

    Reconstition

    To 50 mL with sodium chloride 0.9%

    Route

    IV

    Rate of Administration

    Over a minimum of 30 minutes

    Comments

    OTHER INFORMATION

    Duration of effect about 14 days Used in association with desmopressin (DDAVP) in intractable casesOrally
  • 10 to 20 &nbsp &nbsp : mg daily for 5–7 days Conjugated oestrogens are a mixture of sodium oestrone sulphate and sodium equilin sulphate and other oestrogenic substances of the type excreted by pregnant maresoestrogen, conjugated (unlicensed product).